ConferencePoster
 (2013)

Lapatinib in combination with capecitabine plus oxaliplatin (CapeOx) in HER2-positive advanced or metastatic gastric, esophageal, or gastroesophageal adenocarcinoma (AC): The TRIO-013/LOGiC Trial

J Randolph Hecht,; Qin, Shukui K; Chung, Hyun C; Xu, Jianming M; Park, Joon O; Sobrero, Alberto